199 related articles for article (PubMed ID: 35832552)
1. Risk Factors of Brain Metastasis and Prognosis in HER2-Positive Breast Cancer: A Single-Institution Retrospective Analysis from China.
Cai SL; Wang ZH; Chen XG; Han L; Gong GX; Chen YP; Lin XQ; Ma T; Chen HD
Front Oncol; 2022; 12():905065. PubMed ID: 35832552
[TBL] [Abstract][Full Text] [Related]
2. Analysis of clinicopathological features and prognostic factors of breast cancer brain metastasis.
Chen YR; Xu ZX; Jiang LX; Dong ZW; Yu PF; Zhang Z; Gu GL
World J Clin Oncol; 2023 Nov; 14(11):445-458. PubMed ID: 38059189
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for the development of brain metastases in patients with HER2-positive breast cancer.
Maurer C; Tulpin L; Moreau M; Dumitrescu C; de Azambuja E; Paesmans M; Nogaret JM; Piccart MJ; Awada A
ESMO Open; 2018; 3(6):e000440. PubMed ID: 30425844
[TBL] [Abstract][Full Text] [Related]
4. Interactive effects of molecular subtypes with tumor size and extracranial metastatic pattern on risk of brain metastasis in breast cancer patients: A population-based study.
Shen B; Li J; Yang M; Liu K; Zhang J; Li W; Zhang Y; Wang K
Cancer Med; 2023 Mar; 12(6):6547-6557. PubMed ID: 36353772
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
[TBL] [Abstract][Full Text] [Related]
6. Identification of key genes in HER2-positive breast cancer with brain metastasis via bioinformatics methods.
Yang Z; Sun R; Qu G; Wang F; Yin Z; Zhang T; Wang P; Li S; Lin S
Transl Cancer Res; 2023 May; 12(5):1112-1127. PubMed ID: 37304544
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.
Morikawa A; Wang R; Patil S; Diab A; Yang J; Hudis CA; McArthur HL; Beal K; Seidman AD
Clin Breast Cancer; 2018 Oct; 18(5):353-361. PubMed ID: 29337140
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review.
Hackshaw MD; Danysh HE; Henderson M; Wang E; Tu N; Islam Z; Ladner A; Ritchey ME; Salas M
BMC Cancer; 2021 Aug; 21(1):967. PubMed ID: 34454469
[TBL] [Abstract][Full Text] [Related]
9. Clinical implication of Time To Brain Metastasis (TTBM) according to breast cancer subtypes.
Ahn HK; Park YH; Lee SJ; Park S; Maeng CH; Park W; Choi DH; Hur SJ; Ahn JS; Im YH
Springerplus; 2013 Dec; 2(1):136. PubMed ID: 23667803
[TBL] [Abstract][Full Text] [Related]
10. Brain metastasis in de novo stage IV breast cancer.
He Y; Shao Y; Chen Q; Liu C; Zhu F; Liu H
Breast; 2023 Oct; 71():54-59. PubMed ID: 37499376
[TBL] [Abstract][Full Text] [Related]
11. Changing Natural History of HER2-Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies.
Mounsey LA; Deal AM; Keith KC; Benbow JM; Shachar SS; Zagar T; Dees EC; Carey LA; Ewend MG; Anders CK
Clin Breast Cancer; 2018 Feb; 18(1):29-37. PubMed ID: 28867445
[TBL] [Abstract][Full Text] [Related]
12. Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases?
Darlix A; Lamy PJ; Lopez-Crapez E; Braccini AL; Firmin N; Romieu G; Thézenas S; Jacot W
Int J Cancer; 2016 Nov; 139(10):2299-311. PubMed ID: 27464303
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer brain metastases - A 12 year review of treatment outcomes.
De Ieso PB; Schick U; Rosenfelder N; Mohammed K; Ross GM
Breast; 2015 Aug; 24(4):426-33. PubMed ID: 25881974
[TBL] [Abstract][Full Text] [Related]
14. Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer.
Darlix A; Griguolo G; Thezenas S; Kantelhardt E; Thomssen C; Dieci MV; Miglietta F; Conte P; Braccini AL; Ferrero JM; Bailleux C; Jacot W; Guarneri V
J Neurooncol; 2018 Jun; 138(2):369-382. PubMed ID: 29488184
[TBL] [Abstract][Full Text] [Related]
15. Clinical Outcomes and Prognostic Factors in HER-2 Positive Breast Cancer with Brain Metastasis: A Single-centre Experience.
Karakaya S; Karadag I; Ates O; Cakmak Oksuzoglu OB; Demirci U
J Coll Physicians Surg Pak; 2021 Feb; 31(2):166-170. PubMed ID: 33645183
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development.
Saraf A; Grubb CS; Hwang ME; Tai CH; Wu CC; Jani A; Lapa ME; Andrews JIS; Vanderkelen S; Isaacson SR; Sonabend AM; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Cheng SK; Connolly EP; Wang TJC
J Neurooncol; 2017 Sep; 134(2):453-463. PubMed ID: 28674973
[TBL] [Abstract][Full Text] [Related]
17. Brain metastasis in patients with metastatic breast cancer in the real world: a single-institution, retrospective review of 12-year follow-up.
Matsuo S; Watanabe J; Mitsuya K; Hayashi N; Nakasu Y; Hayashi M
Breast Cancer Res Treat; 2017 Feb; 162(1):169-179. PubMed ID: 28084583
[TBL] [Abstract][Full Text] [Related]
18. CILP, a Putative Gene Associated With Immune Infiltration in Breast Cancer Brain Metastases.
Sun X; Yang N; Zhou X; Dai H; Li Q; Feng A; Xu G; Liu Y; Xu L; Zhang Z; Yang Z; Li X
Front Genet; 2022; 13():862264. PubMed ID: 35711946
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of metastasis and survival between male and female breast cancer with different molecular subtypes: A population-based observational study.
Fang W; Huang Y; Han X; Peng J; Zheng M
Cancer Med; 2022 Feb; 11(3):764-777. PubMed ID: 34898007
[TBL] [Abstract][Full Text] [Related]
20. Clinico-pathologic factors and survival of patients with breast cancer diagnosed with de novo brain metastasis: a national cancer database analysis.
Hijazi A; Mohanna M; Sabbagh S; Herrán M; Dominguez B; Sarna K; Nahleh Z
Breast Cancer Res Treat; 2024 Apr; ():. PubMed ID: 38683296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]